Followers | 261 |
Posts | 19732 |
Boards Moderated | 0 |
Alias Born | 10/03/2004 |
Wednesday, February 24, 2010 4:45:03 PM
My portfolio, that's what.
Obviously, Agora is helping put renewed buying pressure, but the news of the Dengue study certainly has had legs. Good results there and it will get the attention of the military and the CDC as both are focused on that disease. However, one of Dr. Harris's many contacts could take DengueCide into the field and prescribe it for compassionate use in any one of a dozen Central South or Caribbean nations with high numbers of infections.
No, I'm not saying that this would happen, after all humans would require 100 times the amount of material, and that material will be needed just for pre-IND and Phase-1 testing which would alone tax the output of the expanded facility to its limit. (my understanding of its capacity)
However, the path to that IND filing and Phase 1 test just got shorter because of Harris and Berkeley, even if the indication chosen is not Dengue. She brings tremendous credibility to NNVC's technology, credibility not shared even by SRI. So, many now know, and many more are learning of her, and success in her labs will lend tremendous support to other studies such as HIV, HSV and Influenza. On top of that, Harris has a reputation for fast, accurate and reliable testing: very fast, very accurate and very reliable.
Maybe other things going on, but...I can't say.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM